Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why? -- Ignore unavailable to you. Want to Upgrade?

To: Douglas who wrote (344)	2/2/1998 10:27:00 AM
From: Douglas	Respond to of 455

Alert: (CORRECTED)-PROCEPT SAYS GEL FOR PREVENTING HIV SHOWN SAFE IN WOMEN Reuters Story - February 02, 1998 09:44

To: Douglas who wrote (344)	2/2/1998 10:36:00 AM
From: Douglas	Read Replies (1) \| Respond to of 455

In the press release mentioned in Posting #304 it says "Procept is actively seeking strategic partners to further develop its lead candidates for T-cell inhibition and its NMR-based drug development technologies." Why didn't they mention that they are seeking a partner for their Pro 2000? Could it mean that they have concluded or are concluding a partnership agreement for Pro 2000. The last time I spoke to Procept (two-three weeks ago) they mentioned that Procept was almost in a daily contact with a potential partner. Sounds like they were serious. An announcment of a partnership would have a real positive affect on their stock price. Anybody have an opinion?